Cytiva, backed by a $1.5 billion investment from its parent company, the Danaher Group, continued its expansion tear with the acquisition of CEVEC Pharmaceuticals. CEVEC, which is based in Cologne, ...

Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

A new collaboration aims to accelerate genomic medicine by improving manufacturing, scalability, and efficiency in cell and gene therapies, focusing on key bottlenecks in development.

Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of manufacturing ...

AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ -- Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges ...

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities. Cytiva has acquired CEVEC Pharmaceuticals, a Germany-based provider of ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated ...

Cytiva, a Massachusetts-based research and biopharma manufacturing specialist, has opened the doors to its production facility in Cardiff, Wales. The 11,000-square-meter Welsh facility is already ...

Cytiva and the life sciences business of Pall are now one business under the Cytiva brand. With nearly 16,000 associates in 40 countries, and more than 300 years’ heritage of expertise, the new Cytiva ...

Cytiva, the former GE Healthcare Life Sciences, as well as Pall Corp., which specializes in high-tech filtration, separation and purification, announced on Tuesday a plan to invest $1.5 billion ...

Cytiva announced in a Feb. 1, 2021 press release that it had acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines. It is Cytiva’s first acquisition since ...

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular ...